Clonazepam Facts
Depressant;
Description
Clonazepam is a synthetic depressant of the benzodiazepine class. It amplifies GABA — the brain's main calming signal — making neurons less excitable and producing its characteristic sedation and anxiety relief.[1][2]
Subjective effects include anxiety suppression, muscle relaxation, sedation, cognitive slowing, and behavioral disinhibition. The experience is defined by a disconnect between how sober the user feels and how impaired they are — anxiety dissolves and the mind quiets while judgment, memory, and coordination deteriorate unnoticed.[3]
Clonazepam produces physical dependence with regular use; stopping abruptly can trigger life-threatening seizures,[4] though acute toxicity from the drug alone is low. Opioid co-use raises one-year mortality by 78%,[5] and long-term use is a risk factor for cognitive decline in older adults.[6]
Dose and durationby route · individual sensitivity varies
Starts in 20 – 60 minLasts 8 – 12 hoursAfter-effects 8 – 48 hours
Body and dependence
- Acute toxicity
- Low
- Chronic toxicity
- Moderate
- Physical dependence
- High
- Psychological dependence
- High
- Withdrawal
- Life-threatening · fatal · medical supervision
- Compulsive redosing
- Moderate
Tolerance
- Builds
- Rapid
- Fully resets after
- Not recorded
- Carries over to
- diazepam;
alprazolam; lorazepam; chlordiazepoxide; oxazepam; temazepam; alcohol; barbiturates; zolpidem
Effectslikely at a common dose
- Perception
- Dreaming suppression;
+6 possible, including Spatial disorientation, Visual acuity suppression, Vestibular distortion - Body
- Sedation;
Muscle relaxation; Motor control impairment; Physical fatigue; +8 possible, including Dizziness, Respiratory depression, Nystagmus (eye wobbles) - Thinking
- Cognitive impairment;
Decision impairment; +16 possible, including Analysis suppression, Information processing suppression, Memory suppression - Feeling
- Anxiety suppression;
Emotional suppression; +2 possible, including Empathy suppression - Self
- Disinhibition;
+5 possible, including Communication suppression, Craving - Time
- none likely · 2 possible, including Temporal disorientation
Who shouldn't take it
Combinations60 recorded
Seek help immediately if
- Extreme drowsiness — can't stay awake or be roused
- Confusion, slurred speech, severe loss of coordination
- Slow, shallow, or irregular breathing
- Unconsciousness / unresponsive; limp, floppy body
- Blue lips or fingertips
- Vomiting while sedated (choking / aspiration risk)
- Cold, clammy skin; weak pulse
What to do
- Try to wake them — shout, firm sternal rub
- If unresponsive or breathing is impaired, call emergency services
- Place them in the recovery position — critical, they can choke on vomit
- Monitor breathing continuously; be ready to give rescue breaths / CPR
- Never leave them alone to "sleep it off"
- Do not give other drugs, stimulants, or more depressants
Most depressant overdoses resolve with airway protection, breathing support, and monitoring. The danger is respiratory depression and choking on vomit — sharply worse when combined with opioids or alcohol. GHB/GBL overdoses often involve sudden deep unconsciousness and may self-resolve, but airway protection is essential.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Sankar R (2012) GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam. — CNS drugs doi:10.2165/11599020-000000000-00000
- [2]^Navarrete F, Marín-Mayor M, Martínez-Hostyn L, Rubio G, Manzanares J (2026) Benzodiazepine Dependence: Clinical and Molecular Aspects, Preventive Strategies and Therapeutic Approaches. — International journal of molecular sciences doi:10.3390/ijms27031430
- [3]^Dowd SM, Strong MJ, Janicak PG, Negrusz A (2002) The behavioral and cognitive effects of two benzodiazepines associated with drug-facilitated sexual assault. — Journal of forensic sciences PMID:12353555
- [4]
- [5]^Su FY, Tsai MC, Ng YY, Wu SC (2026) The Risk Factors and Mortality Among Patients With Different Combination Patterns of Opioids and Benzodiazepines: A Retrospective Study. — Pharmacology research & perspectives doi:10.1002/prp2.70215
- [6]^Teverovsky EG, Gildengers A, Ran X, et al. (2024) Benzodiazepine use and risk of incident MCI and dementia in a community sample. — International psychogeriatrics doi:10.1017/s1041610223000455